정맥 치료용 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Venous Procedure Devices Market size is expected to reach USD 6.44 Billion in 2034 from USD 3.61 Billion (2025) growing at a CAGR of 6.62% during 2026-2034.

The global venous procedure devices market is growing significantly due to the rising prevalence of venous disorders such as varicose veins and deep vein thrombosis. Increasing awareness about minimally invasive procedures and advancements in medical technologies are encouraging patients to opt for effective treatment solutions. The growing aging population and sedentary lifestyles are also contributing to the increased incidence of venous diseases, thereby driving market growth.

Major drivers include the increasing adoption of endovenous procedures, technological innovations in laser and radiofrequency devices, and improved healthcare infrastructure. These devices offer reduced recovery times, minimal complications, and better clinical outcomes compared to traditional surgical methods. Additionally, the growing availability of specialized vascular treatment centers is enhancing access to advanced venous procedures globally.

In the future, the market is expected to expand with continuous technological advancements and increasing demand for outpatient procedures. The integration of imaging technologies and AI-based diagnostics will improve treatment precision and patient outcomes. Expanding healthcare access in emerging economies and rising investments in vascular care will further drive growth in this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Venous Stents
• Drug Eluting Venous Stent
• Non-drug Eluting Venous Stent
• Catheters
• Central Venous Catheter
• Subcutaneous (Implanted) Port
• Peripherally Inserted Central Catheter (PICC)
• Guidewires
• Standard
• High Support
• Flexible
• Chronic Total Occlusion
• Others

By Application

• Leg
• Chest
• Abdomen
• Arm

By Indication

• Vascular Disease
• Chronic Deep Vein Thrombosis
• Post-thrombotic Syndrome
• May-Thurner Syndrome
• Hemodialysis/Arteriovenous Fistulae
• Others
• Cancer

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

COMPANIES PROFILED

• Medtronic Plc, BD, Cardinal Health, Terumo Corporation, Teleflex Incorporated, Boston Scientific Corporation, Optimed Medizinische Instrumente GmbH, Cook, B Braun Melsungen AG, Abbott Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VENOUS PROCEDURE DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Venous Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Eluting Venous Stent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Non-drug Eluting Venous Stent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Central Venous Catheter Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Subcutaneous (Implanted) Port Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Peripherally Inserted Central Catheter (PICC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Guidewires Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Standard Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. High Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Flexible Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.13. Chronic Total Occlusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.14. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VENOUS PROCEDURE DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Leg Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chest Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Abdomen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Arm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VENOUS PROCEDURE DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Vascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chronic Deep Vein Thrombosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Post-thrombotic Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. May-Thurner Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Hemodialysis/Arteriovenous Fistulae Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VENOUS PROCEDURE DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VENOUS PROCEDURE DEVICES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Indication
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Indication
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Indication
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Indication
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Indication
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VENOUS PROCEDURE DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic Plc
  • 10.2.2 BD
  • 10.2.3 Cardinal Health
  • 10.2.4 Terumo Corporation
  • 10.2.5 Teleflex Incorporated
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Optimed Medizinische Instrumente GmbH
  • 10.2.8 Cook
  • 10.2.9 B. Braun Melsungen AG
  • 10.2.10 Abbott Laboratories